Condition
Localized Prostate Carcinoma
ClinicalTrials.gov condition label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 32 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
32 shownTesting the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate CancerNCT07790718 · 2026-12-16
RECRUITINGMRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate CancerNCT07644598 · 2026-09-01
RECRUITINGStudy of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE TrialNCT07650240 · 2026-08-04
RECRUITINGAssessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CTNCT07455903 · 2026-07-29
RECRUITINGAddressing Health Literacy With a Tailored Survivorship Care PlanNCT06674863 · 2025-11-07
RECRUITINGFeasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During ProstatectomyNCT06940271 · 2025-08-14
RECRUITINGComparison of 177Lu-PSMA-617 and 225Ac-PSMA-617NCT07054346 · 2025-07-08
RECRUITINGTestosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active SurveillanceNCT06733350 · 2025-01-15
RECRUITINGTwo-fraction HDR Monotherapy for Localized Prostate CancerNCT05665738 · 2024-09-11
RECRUITINGAccuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate CancerNCT06389786 · 2024-06-11
RECRUITINGPSMA-Guided Ablation of the ProstateNCT06003556 · 2024-04-02
RECRUITINGTwo-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate CancerNCT06518226 · 2024-03-28
RECRUITINGOnline Adaptive Stereotactic Body Radiotherapy for Localized Prostate CancerNCT06834152 · 2024-03-01
RECRUITINGMulti-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate CancerNCT06200974 · 2024-02-01
RECRUITINGExtraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)NCT06238713 · 2024-01-08
RECRUITINGFocal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate CancerNCT06178354 · 2023-11-09
RECRUITING24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate CancerNCT05936736 · 2023-11-08
RECRUITINGGolf Recreational Exercise for Enhanced Survivorship in Prostate Cancer SurvivorsNCT06500169 · 2023-09-01
RECRUITINGA Study on the Effects of Exercise Therapy on Signs of Prostate CancerNCT05751434 · 2023-02-10
RECRUITINGImmunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer PatientsNCT05045066 · 2021-12-29
RECRUITINGPilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate CancerNCT02526368 · 2016-03-22
RECRUITINGUltra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.NCT05786742 · 2014-04-01
RECRUITINGNeoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate CancerNCT05917860 · 2023-07-18
ACTIVE_NOT_RECRUITINGMagnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate CancerNCT05851365 · 2023-07-06
ACTIVE_NOT_RECRUITINGLiSWT for Nerve Sparing Radical Prostatectomy EDNCT05877144 · 2023-07-06
COMPLETEDTime-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal CancersNCT05722288 · 2023-01-20
ACTIVE_NOT_RECRUITINGRElugolix VErsus LeUprolide Cardiac TrialNCT05320406 · 2022-06-06
ACTIVE_NOT_RECRUITINGDiet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT StudyNCT04870515 · 2021-11-04
COMPLETEDAn Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate CancerNCT04978675 · 2021-08-04
COMPLETEDTesting the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate GlandNCT04530552 · 2021-07-23
COMPLETEDFocal Laser Ablation of Low to Intermediate Prostate Cancer TumorsNCT02600156 · 2015-09-01
COMPLETEDGeneration and Validation of Predictive Models for Localized Prostate Cancer Treated With External Radiotherapy.NCT06092918 · 2013-01-01
COMPLETEDCommon interventions
Biospecimen CollectionPROCEDURE8Questionnaire AdministrationOTHER6Quality-of-Life AssessmentOTHER5Magnetic Resonance ImagingPROCEDURE4Survey AdministrationOTHER4DegarelixDRUG2Exercise InterventionOTHER2InterviewOTHER2LeuprolideDRUG2Medical Device Usage and EvaluationOTHER2Physical Performance TestingOTHER2Positron Emission TomographyPROCEDURE2RelugolixDRUG2177 Lutetium Prostate-Specific Membrane Antigen 617DRUG118-F Flotufolastat PSMA PETDIAGNOSTIC_TEST1Abiraterone AcetateDRUG1Actinium-225 Prostate-Specific Membrane Antigen 617DRUG1Aerobic ExerciseOTHER1AllograftingPROCEDURE1ApalutamideDRUG1Best PracticeOTHER1BicalutamideDRUG1Bilateral Pelvic Lymph Node DissectionPROCEDURE1Biopsy of ProstatePROCEDURE1Biopsy ProcedurePROCEDURE1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Mayo Clinic
5
City of Hope Medical Center
3
Emory University
2
Baptist Health South Florida
1
British Columbia Cancer Agency
1
CHU de Quebec-Universite Laval
1
Consorci Sanitari de Terrassa
1
Fred Hutchinson Cancer Center
1
Georgetown University
1
IRCCS San Raffaele
1
Ivan de Kouchkovsky, MD
1
M.D. Anderson Cancer Center
1
National Cancer Institute (NCI)
1
Robert Flavell, MD, PhD
1
Roswell Park Cancer Institute
1
Trial status mix
RECRUITING22
COMPLETED6
ACTIVE_NOT_RECRUITING4
Phase mix
NA14
PHASE28
EARLY_PHASE13
PHASE13
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.